Covid-19 Diagnostics Market by Sample Type and Test Type- Global Industry Analysis & Forecast to 2027
Published On : September 2020 Pages : 158 Category: In-Vitro Diagnostics Report Code : HC0912942
Covid-19 Diagnostics Market By Sample Type (Nasopharyngeal (NP) Swab, Oropharyngeal (OP) Swab, Nasal Swab, Blood, Others) and Test Type (Molecular (PCR) Testing, Antigen-based Testing, Antibody (Serology) Testing, Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Covid-19 Diagnostics Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Covid-19 commonly known as Corona is an infectious disease caused by the newly discovered Coronavirus that cause major issues or serious illness and even death in older individuals and persons with medical problems. Covid-19 Diagnostics are available in market while the race to curb the trajectory of this virus has become a primary need-of-the-hour for several respective global governments.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Covid-19 Diagnostics Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Thermo Fisher Scientific, Inc.
- Perkin Elmer, Inc.
- Neuberg Diagnostics
- 1drop Inc.
- Veredus Laboratories
- ADT Biotech SdnBhd
- altona Diagnostics GmbH
- bioMérieux SA
- Other Companies
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Covid-19 Diagnostics Market, BySample Type, Estimates and Forecast, 2017-2027 ($Million)
o Nasopharyngeal (NP) Swab
o Oropharyngeal (OP) Swab
o Nasal Swab
o Blood
o Others
· Covid-19 Diagnostics Market, ByTest Type Estimates and Forecast, 2017-2027 ($Million)
o Molecular (PCR) Testing
o Antigen-based Testing
o Antibody (Serology) Testing
o Others
· Covid-19 Diagnostics Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Thermo Fisher Scientific, Inc.
o Perkin Elmer, Inc.
o Neuberg Diagnostics
o 1drop Inc.
o Veredus Laboratories
o ADT Biotech SdnBhd
o altona Diagnostics GmbH
o bioMérieux SA
· Covid-19 Diagnostics Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Covid-19 Diagnostics Market, By Country
o U.S. Covid-19 Diagnostics Market
o Canada Covid-19 Diagnostics Market
o Mexico Covid-19 Diagnostics Market
o Europe
§ Europe Covid-19 Diagnostics Market, By Country
o UK Covid-19 Diagnostics Market
o Germany Covid-19 Diagnostics Market
o France Covid-19 Diagnostics Market
o Russia Covid-19 Diagnostics Market
o Italy Covid-19 Diagnostics Market
o Rest of Europe Covid-19 Diagnostics Market
o Asia-Pacific
§ Asia-Pacific Covid-19 Diagnostics Market, By Country
o China Covid-19 Diagnostics Market
o Japan Covid-19 Diagnostics Market
o South Korea Covid-19 Diagnostics Market
o India Covid-19 Diagnostics Market
o Southeast Asia Covid-19 Diagnostics Market
o Rest of Asia-Pacific Covid-19 Diagnostics Market
o South America
§ South America Covid-19 Diagnostics Market
o Brazil Covid-19 Diagnostics Market
o Argentina Covid-19 Diagnostics Market
o Columbia Covid-19 Diagnostics Market
o Rest of South America Covid-19 Diagnostics Market
o Middle East and Africa
§ Middle East and Africa Covid-19 Diagnostics Market
o Saudi Arabia Covid-19 Diagnostics Market
o UAE Covid-19 Diagnostics Market
o Egypt Covid-19 Diagnostics Market
o Nigeria Covid-19 Diagnostics Market
o South Africa Covid-19 Diagnostics Market
o TurkeyCovid-19 Diagnostics Market
o Rest of MEA Covid-19 Diagnostics Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Covid-19 Diagnostics Market, By Sample Type
5.1. Introduction
5.2. Global Covid-19 Diagnostics Revenue and Market Share by Sample Type (2017-2021)
5.2.1. Global Covid-19 Diagnostics Revenue and Revenue Share by Sample Type (2017-2021)
5.3. Nasopharyngeal (NP) Swab
5.3.1. Global Nasopharyngeal (NP) Swab Revenue and Growth Rate (2017-2021)
5.4. Oropharyngeal (OP) Swab
5.4.1. Global Oropharyngeal (OP) Swab Revenue and Growth Rate (2017-2021)
5.5. Nasal Swab
5.5.1. Global Nasal Swab Revenue and Growth Rate (2017-2021)
5.6. Blood
5.6.1. Global Blood Revenue and Growth Rate (2017-2021)
5.7. Others
5.7.1. Global Others Revenue and Growth Rate (2017-2021)
6. Covid-19 Diagnostics Market, By Test Type
6.1. Introduction
6.2. Global Covid-19 Diagnostics Revenue and Market Share by Test Type (2017-2021)
6.2.1. Global Covid-19 Diagnostics Revenue and Revenue Share by Test Type (2017-2021)
6.3. Molecular (PCR) Testing
6.3.1. Global Molecular (PCR) Testing Revenue and Growth Rate (2017-2021)
6.4. Antigen-based Testing
6.4.1. Global Antigen-based Testing Revenue and Growth Rate (2017-2021)
6.5. Antibody (Serology) Testing
6.5.1. Global Antibody (Serology) Testing Revenue and Growth Rate (2017-2021)
6.6. Others
6.6.1. Global Others Revenue and Growth Rate (2017-2021)
7. Covid-19 Diagnostics Market, By Region
7.1. Introduction
7.2. Global Covid-19 Diagnostics Revenue and Market Share by Regions
7.2.1. Global Covid-19 Diagnostics Revenue by Regions (2017-2021)
7.3. North America Covid-19 Diagnostics by Countries
7.3.1. North America Covid-19 Diagnostics Revenue and Growth Rate (2017-2021)
7.3.2. North America Covid-19 Diagnostics Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Covid-19 Diagnostics by Countries
7.4.1. Europe Covid-19 Diagnostics Revenue and Growth Rate (2017-2021)
7.4.2. Europe Covid-19 Diagnostics Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Covid-19 Diagnostics by Countries
7.5.1. Asia-Pacific Covid-19 Diagnostics Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Covid-19 Diagnostics Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Covid-19 Diagnostics by Countries
7.6.1. South America Covid-19 Diagnostics Revenue and Growth Rate (2017-2021)
7.6.2. South America Covid-19 Diagnostics Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Covid-19 Diagnostics by Countries
7.7.1. Middle East and Africa Covid-19 Diagnostics Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Covid-19 Diagnostics Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Thermo Fisher Scientific, Inc.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Perkin Elmer, Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Neuberg Diagnostics
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. 1drop Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Veredus Laboratories
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. ADT Biotech Sdn Bhd
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. altona Diagnostics GmbH
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. bioMérieux SA
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Other Companies
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Covid-19 Diagnostics Market Forecast (2022-2027)
9.1. Global Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Covid-19 Diagnostics Market Forecast by Regions (2022-2027)
9.2.1. North America Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.1.1. United States Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.1.2. Canada Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.1.3. Mexico Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.2. Europe Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.2.1. Germany Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.2.2. France Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.2.3. UK Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.2.4. Russia Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.2.5. Italy Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.3. Asia-Pacific Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.3.1. China Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.3.2. Japan Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.3.3. Korea Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.3.4. India Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.4. South America Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.4.1. Brazil Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.4.2. Argentina Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.4.3. Columbia Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.4.4. Rest of South America Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.5. Middle East and Africa Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.5.3. Egypt Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.5.4. Nigeria Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.5.5. South Africa Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.5.6. Turkey Covid-19 Diagnostics Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Covid-19 Diagnostics Market Forecast (2022-2027)
9.3. Covid-19 Diagnostics Market Forecast by Sample Type (2022-2027)
9.3.1. Covid-19 Diagnostics Forecast by Sample Type (2022-2027)
9.3.2. Covid-19 Diagnostics Market Share Forecast by Sample Type (2022-2027)
9.4. Covid-19 Diagnostics Market Forecast by Test Type (2022-2027)
9.4.1. Covid-19 Diagnostics Forecast by Test Type (2022-2027)
9.4.2. Covid-19 Diagnostics Market Share Forecast by Test Type (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Covid-19 Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Covid-19 Diagnostics Revenue and Revenue Share by Sample Type (2017-2019)
Figure Global Nasopharyngeal (NP) Swab Revenue and Growth Rate (2017-2019)
Figure Global Oropharyngeal (OP) Swab Revenue and Growth Rate (2017-2019)
Figure Global Nasal Swab Revenue and Growth Rate (2017-2019)
Figure Global Blood Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Covid-19 Diagnostics Revenue and Revenue Share by Test Type (2017-2019)
Figure Global Molecular (PCR) Testing Revenue and Growth Rate (2017-2019)
Figure Global Antigen-based Testing Revenue and Growth Rate (2017-2019)
Figure Global Antibody (Serology) Testing Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Covid-19 Diagnostics Revenue by Regions (2017-2019)
Figure North America Covid-19 Diagnostics Growth Rate (2017-2019)
Figure North America Covid-19 Diagnostics Revenue and Growth Rate (2017-2019)
Figure North America Covid-19 Diagnostics by Countries (2017-2019)
Figure North America Covid-19 Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure United States Covid-19 Diagnostics Growth Rate (2017-2019)
Figure United States Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Canada Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Mexico Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Europe Covid-19 Diagnostics Revenue and Growth Rate (2017-2019)
Figure Europe Covid-19 Diagnostics by Countries (2017-2019)
Figure Europe Covid-19 Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure Germany Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Germany Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Covid-19 Diagnostics Growth Rate (2017-2019)
Figure France Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Covid-19 Diagnostics Growth Rate (2017-2019)
Figure UK Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Russia Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Italy Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Rest of Europe Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Asia-Pacific Covid-19 Diagnostics Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Covid-19 Diagnostics by Countries (2017-2019)
Figure Asia-Pacific Covid-19 Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure China Covid-19 Diagnostics Growth Rate (2017-2019)
Figure China Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Japan Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Korea Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Covid-19 Diagnostics Growth Rate (2017-2019)
Figure India Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Southeast Asia Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Covid-19 Diagnostics Growth Rate (2017-2019)
Figure South America Covid-19 Diagnostics Revenue and Growth Rate (2017-2019)
Figure South America Covid-19 Diagnostics by Countries (2017-2019)
Figure South America Covid-19 Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Brazil Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Argentina Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Columbia Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Rest of South America Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Middle East and Africa Covid-19 Diagnostics Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Covid-19 Diagnostics by Countries (2017-2019)
Figure Middle East and Africa Covid-19 Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Saudi Arabia Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Covid-19 Diagnostics Growth Rate (2017-2019)
Figure United Arab Emirates Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Egypt Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Nigeria Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Covid-19 Diagnostics Growth Rate (2017-2019)
Figure South Africa Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Turkey Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Covid-19 Diagnostics Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Table Thermo Fisher Scientific, Inc. Covid-19 Diagnostics Financial Overview
Table Perkin Elmer, Inc. Covid-19 Diagnostics Financial Overview
Table Neuberg Diagnostics Covid-19 Diagnostics Financial Overview
Table 1drop Inc. Covid-19 Diagnostics Financial Overview
Table Veredus Laboratories Covid-19 Diagnostics Financial Overview
Table ADT Biotech Sdn Bhd Covid-19 Diagnostics Financial Overview
Table altona Diagnostics GmbH Covid-19 Diagnostics Financial Overview
Table bioMérieux SA Covid-19 Diagnostics Financial Overview
Table Other Companies Covid-19 Diagnostics Financial Overview
Figure Global Covid-19 Diagnostics Revenue (Millions USD) and Growth Rate (2019-2027)
Table Covid-19 Diagnostics Market Forecast by Regions (2019-2027)
Figure North America Covid-19 Diagnostics Market Forecast (2019-2027)
Figure United States Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Canada Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Mexico Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Europe Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Germany Covid-19 Diagnostics Market Forecast (2019-2027)
Figure France Covid-19 Diagnostics Market Forecast (2019-2027)
Figure UK Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Russia Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Italy Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Rest of Europe Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Asia-Pacific Covid-19 Diagnostics Market Forecast (2019-2027)
Figure China Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Japan Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Korea Covid-19 Diagnostics Market Forecast (2019-2027)
Figure India Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Southeast Asia Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Covid-19 Diagnostics Market Forecast (2019-2027)
Figure South America Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Brazil Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Argentina Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Columbia Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Rest of South America Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Middle East and Africa Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Saudi Arabia Covid-19 Diagnostics Market Forecast (2019-2027)
Figure United Arab Emirates Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Egypt Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Nigeria Covid-19 Diagnostics Market Forecast (2019-2027)
Figure South Africa Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Turkey Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Covid-19 Diagnostics Market Forecast (2019-2027)
Figure Global Covid-19 Diagnostics Forecast by Sample Type (2019-2027)
Figure Global Covid-19 Diagnostics Market Share Forecast by Sample Type (2019-2027)
Figure Global Covid-19 Diagnostics Forecast by Sample Type (2019-2027)
Figure Global Covid-19 Diagnostics Forecast by Test Type (2019-2027)
Figure Global Covid-19 Diagnostics Market Share Forecast by Test Type (2019-2027)
Figure Global Covid-19 Diagnostics Forecast by Test Type (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|